Introduction
Cancer is a multifactorial disease characterized by uncontrolled cell proliferation, genetic instability, immune evasion, and metabolic dysregulation. Despite significant advancements in modern oncology—including surgery, chemotherapy, radiotherapy, targeted therapy, and immunotherapy—treatment-related toxicity and reduced quality of life remain major challenges. This has led to growing interest in integrative oncology, which combines evidence-based complementary therapies with conventional cancer treatments. Among traditional systems, Ayurveda offers a holistic framework that emphasizes restoring systemic balance, strengthening host resilience, and supporting long-term health outcomes. The integration of Ayurvedic medicine with modern cancer therapeutics presents a promising pathway for comprehensive cancer care.
Ayurvedic perspective on cancer
In Ayurveda, cancer-like conditions are conceptually associated with Arbuda (tumorous growths) and Granthi (nodular formations). These conditions arise due to imbalances in the three Doshas—Vata, Pitta, and Kapha—along with impaired digestive fire (Agni) and accumulation of metabolic toxins (Ama). The disruption of Agni leads to improper digestion and assimilation, resulting in systemic toxicity and tissue-level dysfunction. Additionally, obstruction of bodily channels (Srotas) contributes to abnormal tissue proliferation and impaired cellular regulation.
This systemic view contrasts with the localized tumor-centric approach of modern oncology, offering a broader perspective that includes metabolic, immunological, and physiological dimensions of disease.
Immunomodulatory and anticancer potential of Ayurvedic herbs
A key aspect of Ayurvedic oncology is the use of medicinal plants with immunomodulatory, antioxidant, and cytoprotective properties. Herbs such as Withania somnifera (Ashwagandha), Tinospora cordifolia (Guduchi), and Curcuma longa (Turmeric) are widely studied for their potential role in cancer management.
Curcumin, the active compound in turmeric, has demonstrated activity against multiple molecular pathways involved in carcinogenesis, including NF-κB, STAT3, and various apoptotic regulators. Similarly, Ashwagandha exhibits adaptogenic and immune-enhancing effects that may help reduce stress-induced immunosuppression in cancer patients. Guduchi is known for its anti-inflammatory and immunoregulatory properties, which may support host defense mechanisms during cancer progression and treatment.
While preclinical studies have shown promising results, further large-scale clinical trials are necessary to establish standardized therapeutic protocols.
Supportive care and symptom management
One of the most valuable contributions of Ayurveda in oncology is supportive care aimed at improving quality of life and reducing treatment-related side effects. Chemotherapy and radiotherapy often cause adverse effects such as nausea, fatigue, mucositis, neuropathy, and immune suppression. Ayurvedic interventions can help mitigate these symptoms and enhance treatment tolerance.
Ginger is commonly used to reduce chemotherapy-induced nausea and vomiting. Triphala, a classical Ayurvedic formulation composed of Terminalia chebula, Terminalia bellirica, and Emblica officinalis, supports gastrointestinal health and detoxification. Additionally, dietary regulation (Pathya), herbal formulations, and lifestyle interventions such as yoga and meditation contribute to emotional stability, stress reduction, and improved patient well-being.
Integrative oncology: A multidimensional approach
Integrative oncology represents a patient-centered model that combines conventional cancer therapies with complementary traditional medicine systems. This approach aims to enhance therapeutic efficacy, minimize toxicity, and improve overall quality of life. Ayurveda contributes to this model by offering individualized treatment strategies based on Prakriti (constitution), disease stage, and patient resilience.
However, integration requires careful scientific validation, standardized herbal preparations, and monitoring for herb–drug interactions to ensure safety and efficacy. The collaboration between oncologists, pharmacologists, and traditional medicine practitioners is essential for developing evidence-based integrative protocols.
Conclusion
The integration of Ayurvedic medicine with modern cancer therapeutics offers a comprehensive framework for addressing the complex nature of cancer. While modern oncology focuses on tumor eradication, Ayurveda emphasizes systemic balance, immunity enhancement, and holistic healing. Together, they provide a complementary approach that can improve treatment outcomes and patient quality of life. Continued research, clinical validation, and interdisciplinary collaboration are essential to fully harness the potential of integrative oncology in advancing cancer care.1
References:
- Jha SK, Singh N, Shanker OR, Antil I, Baghel JS, Huddar V, Tripathi R. A review on integrative approaches in oncology: bridging Ayurvedic medicine and modern cancer therapeutics. Front Nat Prod. 2025;4:1635197. doi:10.3389/fntpr.2025.1635197. https://www.frontiersin.org/journals/natural-products/articles/10.3389/fntpr.2025.1635197/full